72934-36-2

Usage

Uses

Used in Pharmaceutical Industry:
1-(4-CHLORO-PHENYL)-CYCLOPROPYLAMINE is used as a building block for the synthesis of various biologically active molecules, including potential drug candidates. Its 4-chlorophenyl group allows for the modification of the compound's reactivity and properties, making it valuable in medicinal chemistry and drug discovery.
Used in Academic Research:
In academic research, 1-(4-CHLORO-PHENYL)-CYCLOPROPYLAMINE is used as a reagent for the development of new synthetic methodologies. Its unique structure and functional groups contribute to the advancement of chemical synthesis techniques.
Safety Precautions:
As a potentially hazardous chemical, 1-(4-CHLORO-PHENYL)-CYCLOPROPYLAMINE should be handled and used with appropriate safety measures to ensure the well-being of individuals and the environment.

InChI:InChI=1/C9H10ClN/c10-8-3-1-7(2-4-8)9(11)5-6-9/h1-4H,5-6,11H2

Upstream product

• 623-03-0 4-Cyanochlorobenzene 
• 557-20-0 diethylzinc 
• 1095661-33-8 tert-butyl (1-(4-chlorophenyl)cyclopropyl)carbamate 
• 140-53-4 p-chlorobenzyl cyanide 
• 64399-27-5 1-(4-chlorophenyl)-1-cyclopropanecarbonitrile 
• 72934-37-3 3-(4-chlorophenyl)-1-cyclopropanecarboxylic acid 
• 72934-38-4 trans-4-chlorophenylcyclopropyl isocyanate 

Downstream Products

• 1620775-46-3 methyl 4-(4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy-D₂)-1,3,5-triazin-2-ylamino)benzoate 
• 1422356-77-1 C₄₀H₅₄ClNO₄ 
• 1449410-48-3 methyl 4-{[4-{[1-(4-chlorophenyl)cyclopropyl]amino}-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}-3-fluorobenzoate 
• 1360828-40-5 tert-butyl 4-((4-((1-(4-chlorophenyl)cyclopropyl)amino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl)amino)benzoate 
• 72934-39-5 1-[1-(4-Chloro-phenyl)-cyclopropyl]-3-phenyl-thiourea 

Relevant academic research and scientific papers

C-3 NOVEL TRITERPENONE WITH C-28 UREA DERIVATIVES AS HIV INHIBITORS

The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.

INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)

The present invention provides a compound of formula (I): a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

USE OF COMPOUNDS FOR PREPARING ANTI-TUBERCULOSIS AGENTS

Compounds of a compound of compound of general formula (I) wherein X1, X2, A, R1R2, R3 and R4 are as defined herein; are useful as anti-mycobacterial agents, especially agents for the treatment of tuberculosis.

Substituted pteridines for the treatment of inflammatory diseases

The invention relates to new pteridines which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers, as

Primary 1-Arylcyclopropylamines from aryl cyanides with diethylzinc and titanium alkoxides

(Matrix presented) 1-Aryl-substituted primary cyclopropylamines are conveniently prepared from aromatic nitriles and diethylzinc. The yields range from 40 to 56% for donor-substituted (five examples) to 62-82% for non- and acceptor-substituted substrates